Free Review Articles on Heart failure (chronical)                                 Metatextbook

Freie Reviews über Herzinsuffizienz (chronisch)                                 Look here for Journal Homepages

  • Heart failure (chronical)
  • Coronary heart disease (BASKET)
  • Heart (Cardiomyoplasty)
  • Heart failure (BASKET)
  • Uric acid
  • Nebivolol
  • Statin
  • Heart (Arrhythmia)
  • G Protein coupled receptor
  • Diuretic agents (BASKET)
  • Receptor (RyR2)
  • Heart failure (acute)
  • Receptor (Catecholamines)
  • Receptor (Catecholamines beta)
  • Cardiac pacemaker (biventricular)
  • Sleep apnea (central)
  • Autoantibodies Anti beta1 adrenorezeptor
  • Beta adrenergic antagonists
  • Baroreflex
  • Cardiology (BASKET)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12005Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.



    		+-nlQJM 98(7):493-7 (2005)
    22002Heart failure in older people: causes, diagnosis and treatment.



    		+-nlAge Ageing 31(1):29-36 (2002)
    32002Beta-blockers in left ventricular systolic dysfunction--from evidence to practice.



    		+-nlAge Ageing 31(1):23-8 (2002)
    42000Beta-blockers: the new standard of therapy for mild heart failure.



    		+-nlArch Intern Med 160(9):1237-47 (2000)
    52000Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials.



    		+-nlArch Intern Med 160(5):621-7 (2000)
    61999Newer drug therapy for congestive heart failure.



    		+-nlArch Intern Med 159(11):1177-83 (1999)
    71999Sympathetic activation in heart failure and its treatment with beta-blockade.



    		+-nlArch Intern Med 159(3):225-34 (1999)
    82009A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.



    		+-nlNeth J Med 67(9):284-94 (2009)
    92003New developments in the management of heart failure: a review of the literature in 2002.



    		+-nlNeth J Med 61(5 Suppl):19-27 (2003)
    102006Aldosterone receptor antagonists for heart failure: current status, future indications.



    		+-nlCleve Clin J Med 73(3):257-60, 264-8 (2006)
    112008Carvedilol in the treatment of elderly patients with chronic heart failure.



    		+-nlClin Interv Aging 3(1):55-70 (2008)
    122007Management of end stage heart failure.



    		+-nlHeart 93(5):626-31 (2007)
    132007Surgery for heart failure.



    		+-nlHeart 93(3):392-402 (2007)
    142006Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients.



    		+-nlHeart 92(12):1728-31 (2006)
    152006Origin of symptoms in chronic heart failure.



    		+-nlHeart 92(1):12-6 (2006)
    162005Systematic review of multidisciplinary interventions in heart failure.



    		+-nlHeart 91(7):899-906 (2005) Holland R
    172005Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?



    		+-nlHeart 91(6):707-9 (2005)
    182002Heart failure: aetiology, diagnosis, and treatment.



    		+-nlHeart 88(6):567-9 (2002)
    192002Heart failure in the young.



    		+-nlHeart 88(2):198-202 (2002)
    202001Heart failure: What causes the symptoms of heart failure?



    		+-nlHeart 86(5):574-8 (2001)
    212000Epidemiology, aetiology, and prognosis of heart failure.



    		+-nlHeart 83(5):596-602 (2000)
    221999Major beta blocker mortality trials in chronic heart failure: a critical review.



    		+-nlHeart 82 Suppl 4(-):IV14-22 (1999)
    231998Angiotensin II receptor antagonists for heart failure.



    		+-nlHeart 80(1):5-6 (1998)
    241997The origin of symptoms in chronic heart failure.



    		+-nlHeart 78(5):429-30 (1997)
    251996Inhibitors of the renin-angiotensin system in established cardiac failure.



    		+-nlHeart 76(3 Suppl 3):83-91 (1996)
    261994How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?



    		+-nlBr Heart J 72(3 Suppl):S81-6 (1994)
    271994Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?



    		+-nlBr Heart J 72(3 Suppl):S75-80 (1994)
    281994Results of clinical trials with diuretics in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S68-72 (1994)
    291994Physiological rationale for co-treatment with diuretics in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S63-7 (1994)
    301994Diuretic induced changes in symptoms and quality of life.



    		+-nlBr Heart J 72(2 Suppl):S57-62 (1994)
    311994Electrophysiological impact of diuretics in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S54-6 (1994)
    321994Neuroendocrine effects of diuretics in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S51-3 (1994)
    331994Vascular effects of diuretics in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S48-50 (1994)
    341994Haemodynamic effects of diuretics in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S44-7 (1994)
    351994Neuroendocrine excitation in heart failure.



    		+-nlBr Heart J 72(2 Suppl):S28-30 (1994)
    361994Peripheral circulatory adaptations to pump failure of the heart.



    		+-nlBr Heart J 72(2 Suppl):S22-7 (1994)
    371994Central haemodynamic expressions of heart failure.



    		+-nlBr Heart J 72(2 Suppl):S18-21 (1994)
    381994Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance.



    		+-nlBr Heart J 72(2 Suppl):S10-7 (1994)
    391993Beta blockers and the failing heart: is it time for a U-turn?



    		+-nlBr Heart J 70(1):8-12 (1993)
    401993Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?



    		+-nlBr Heart J 69(4):282-3 (1993)
    411991Vascular tone in heart failure: the neuroendocrine-therapeutic interface.



    		+-nlBr Heart J 66(4):264-7 (1991)
    421987Congestive cardiac failure: central role of the arterial blood pressure.



    		+-nlBr Heart J 58(3):190-203 (1987)
    431985Drug treatment of heart failure.



    		+-nlBr Heart J 54(3):234-42 (1985)
    442009Heart failure as a multiple hormonal deficiency syndrome.



    		+-nlCirc Heart Fail 2(2):151-6 (2009)
    452009Immunological mechanisms of pentoxifylline in chronic heart failure.



    		+-nlEur J Heart Fail 11(2):113-8 (2009) Shaw SM
    461998Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials.



    		+-nlCan J Cardiol 14(8):1045-53 (1998)
    472009Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.



    		+-nlCardiovasc Ther 27(3):187-93 (2009)
    482008Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.



    		+-nlJACC Cardiovasc Imaging 1(4):536-55 (2008)
    492007Nebivolol in the treatment of chronic heart failure.



    		+-nlVasc Health Risk Manag 3(5):647-54 (2007)
    502007A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus.



    		+-nlVasc Health Risk Manag 3(5):639-45 (2007)
    512007Aldosterone antagonism in heart failure.



    		+-nlVasc Health Risk Manag 3(5):605-9 (2007)
    522007Bisoprolol in the treatment of chronic heart failure.



    		+-nlVasc Health Risk Manag 3(4):431-9 (2007)
    532008Sarcomeric dysfunction in heart failure.



    		+-nlCardiovasc Res 77(4):649-58 (2008)
    542006Statins in the treatment of chronic heart failure: biological and clinical considerations.



    		+-nlCardiovasc Res 71(3):443-54 (2006)
    552005Something old, something new: changing views on the cellular mechanisms of heart failure.



    		+-nlCardiovasc Res 68(2):167-74 (2005) Sipido KR
    562004Electrophysiological changes in heart failure and their relationship to arrhythmogenesis.



    		+-nlCardiovasc Res 61(2):208-17 (2004) Janse MJ
    572003Do we understand why regression of left ventricular hypertrophy is beneficial?



    		+-nlCardiovasc Res 60(3):463-4 (2003)
    582003Relevance of Na+-Ca2+ exchange in heart failure.



    		+-nlCardiovasc Res 57(4):921-33 (2003)
    592003The Na, K-ATPase in the failing human heart.



    		+-nlCardiovasc Res 57(4):913-20 (2003)
    602003[Na+]i handling in the failing human heart.



    		+-nlCardiovasc Res 57(4):874-86 (2003)
    612002Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis.



    		+-nlCardiovasc Res 54(3):516-27 (2002)
    622002The failing human heart.



    		+-nlCardiovasc Res 54(1):1-10 (2002)
    632001Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.



    		+-nlCardiovasc Res 51(3):495-509 (2001)
    642001Defining heart failure.



    		+-nlCardiovasc Res 50(3):419-22 (2001)
    652001Mitochondrial pathology in cardiac failure.



    		+-nlCardiovasc Res 49(1):17-26 (2001)
    661999Electrophysiological remodeling in hypertrophy and heart failure.



    		+-nlCardiovasc Res 42(2):270-83 (1999)
    671997Beta-adrenoceptor blockers in chronic heart failure--a review.



    		+-nlBr J Clin Pharmacol 44(2):111-8 (1997)
    681989Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.



    		+-nlBr J Clin Pharmacol 27(5):527-37 (1989)
    691999Regulation of beta-adrenoceptor signaling in cardiac function and disease.



    		+-nlPharmacol Rev 51(3):465-501 (1999)
    702004The adrenergic pathway and heart failure.



    		+-nlRecent Prog Horm Res 59(-):13-30 (2004)
    712007Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications.



    		+-nlJ Thromb Haemost 5(2):224-31 (2007)
    721988Congestive heart failure.



    		+-nlCMAJ 138(8):689-94 (1988)
    732007Beta blockers for congestive heart failure.



    		+-nlActa Med Indones 39(1):44-8 (2007)
    742009The failing ventricle: what initiates the complex ventricular arrhythmias?



    		+-nlAm J Physiol Heart Circ Physiol 297(4):H1198-9 (2009) Boyden PA
    752007Cardiac GPCRs: GPCR signaling in healthy and failing hearts.



    		+-nlBiochim Biophys Acta 1768(4):1006-18 (2007)
    762006The role of vasopressin in congestive heart failure.



    		+-nlCleve Clin J Med 73 Suppl 3(-):S19-23 (2006)
    772010Biofeedback in the treatment of heart failure.



    		+-nlCleve Clin J Med 77 Suppl 3(-):S56-9 (2010)
    782011Electrical vagus nerve stimulation for the treatment of chronic heart failure.



    		+-nlCleve Clin J Med 78 Suppl 1(-):S24-9 (2011)
    792006Sodium and water retention in heart failure and diuretic therapy: basic mechanisms.



    		+-nlCleve Clin J Med 73 Suppl 2(-):S2-7; discussion S30-3 (2006)
    802011Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?



    		+-nlMayo Clin Proc 86(6):531-9 (2011)
    812010Chronic heart failure: contemporary diagnosis and management.



    		+-nlMayo Clin Proc 85(2):180-95 (2010)
    822009Beta-blocker use for the stages of heart failure.



    		+-nlMayo Clin Proc 84(8):718-29 (2009)
    832007Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets.



    		+-nlPhysiology (Bethesda) 22(-):56-64 (2007)
    842010A leakage leads to failure: roles of sarcoplasmic reticulum Ca2+ leak via RyR2 in heart failure progression.



    		+-nlHypertension 55(4):849-51 (2010)
    8520092009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.



    		+-nlCirculation 119(14):e391-479 (2009)
    8620092009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.



    		+-nlCirculation 119(14):1977-2016 (2009)
    872009The heart failure spectrum: time for a phenotype-oriented approach.



    		+-nlCirculation 119(24):3044-6 (2009)
    882011Cardiac-troponin-guided heart failure management: is it possible in clinical practice?



    		+-nlCirc J 75(3):542-3 (2011) Inomata T
    892008ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).



    		+-nlEur Heart J 29(19):2388-442 (2008)
    902009Pathophysiology of chronic heart failure.



    		+-nlRev Port Cardiol 28(4):439-71 (2009)
    912008Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction.



    		+-nlRev Port Cardiol 27(6):851-6 (2008)
    922006Cardiac adrenoceptors: physiological and pathophysiological relevance.



    		+-nlJ Pharmacol Sci 100(5):323-37 (2006)
    932008Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy.



    		+-nlEuropace 10(9):1029-33 (2008)
    942011New therapeutic targets for the development of positive inotropic agents.



    		+-nlDiscov Med 12(66):381-92 (2011)
    952004Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation.



    		+-nlJ Clin Invest 113(10):1379-82 (2004)
    962009Heart failure management: the present and the future.



    		+-nlAntioxid Redox Signal 11(8):1989-2010 (2009)
    972009Gene and cell therapy for heart failure.



    		+-nlAntioxid Redox Signal 11(8):2025-42 (2009)
    982011The challenge of comprehensive disease management in heart failure.



    		+-nlIsr Med Assoc J 13(8):494-5 (2011) Silber H
    992009Immunological mediated therapies for heart failure.



    		+-nlIsr Med Assoc J 11(5):301-5 (2009)
    1002009Use of aldosterone antagonists in heart failure.



    		+-nlJAMA 302(15):1658-65 (2009)
    1012010Heart failure with normal ejection fraction (HFNEF): is it worth considering?



    		+-nlSwiss Med Wkly 140(5-6):66-72 (2010)
    1022010Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.



    		+-nlVasc Health Risk Manag 6(-):387-97 (2010)
    1032011The causes, consequences, and treatment of left or right heart failure.



    		+-nlVasc Health Risk Manag 7(-):237-54 (2011)
    1042007Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.



    		+-nlVasc Health Risk Manag 3(1):31-7 (2007)
    1052011Heart failure with preserved ejection fraction: fighting misconceptions for a new approach.



    		+-nlArq Bras Cardiol 96(6):504-14 (2011)
    1062010Treatment of heart failure with normal ejection fraction.



    		+-nlArq Bras Cardiol 94(3):391-402, 414-26 (2010)
    1072010Heart failure with normal ejection fraction.



    		+-nlArq Bras Cardiol 94(5):652-60, 694-702 (2010)
    1082011Behavior of central and peripheral chemoreflexes in heart failure.



    		+-nlArq Bras Cardiol 96(2):161-7 (2011)
    1092005I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure.



    		+-nlArq Bras Cardiol 85 Suppl 3(-):49-94; 1-48 (2005)
    1102009Drug therapy of cardiac diseases in children.



    		+-nlIndian Pediatr 46(4):310-38 (2009)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.